MedPath

Endometriosis and ATR-FTIR Spectroscopy

Not Applicable
Recruiting
Conditions
Endometriomas
Endometriosis
Registration Number
NCT06426420
Lead Sponsor
Federal University of Espirito Santo
Brief Summary

The goal of this study is to explore the use of mid-infrared spectroscopy (ATR-FTIR) as a detection tool for endometriosis in urine.

Detailed Description

Endometriosis is a chronic gynecological disease that is considered debilitating and multifactorial. Its diagnosis is invasive and can be prolonged due to non-specific symptoms and erroneous or late investigations, which can lead to delays and impair the provision of adequate treatment.

ATR-FTIR Spectroscopy is a non-invasive technique with the capability to identify the chemical composition and molecular changes of samples through its interaction with mid-infrared radiation. The aim of this work is to develop a rapid test for the detection of endometriosis in urine samples using spectroscopy and machine learning algorithms.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • Female
  • Pelvic pain complain
Exclusion Criteria
  • Age under 18 or above 55
  • Lack of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Spectroscopy Reliability (diagnostic metrics)1 year

The primary outcome is the evaluation of specificity, sensitivity and accuracy of the diagnostic. Acceptable diagnostic metrics must be comparable to MRI, which will demonstrate if spectroscopy can discriminate between negative and positive endometriosis patients.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Cassiano Antonio Moraes at Federal Univeristy Of Espírito Santo

🇧🇷

Vitória, Espírito Santo, Brazil

University Hospital Cassiano Antonio Moraes at Federal Univeristy Of Espírito Santo
🇧🇷Vitória, Espírito Santo, Brazil
Neide A Boldrini, phD
Principal Investigator
Mara RB Barcelos, phD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.